http://localhost:8080/xmlui/handle/123456789/45 2026-05-03T04:56:38Z http://localhost:8080/xmlui/handle/123456789/360 Ureterocele in Combination with Urolithiasis in a Pregnant Woman Khairli, G.; Zhanbyrbekuly, U.; Suchshenko, A.; Kazhitaev, A. M.; Alnagiev, R. Z.; Ismailov, O. A.; Akhmetkhan, D. D.; Baigozha, A. Zh. This article is devoted to the description of the clinical picture, methods of laboratory and instrumental diagnostics, the choice of surgical treatment and postoperative rehabilitation of a patient with a rare urological pathology - ureterocele in combination with urolithiasis in a pregnant woman. This article is devoted to the description of the clinical picture, methods of laboratory and instrumental diagnostics, the choice of surgical treatment and postoperative rehabilitation of a patient with a rare urological pathology - ureterocele in combination with urolithiasis in a pregnant woman. 2023-01-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/359 Subclinical Hypothyroidism and Functional Hemodynamics of the Heart Aringazina, R. A.; Abenova, N.; Ahmad Bhat, S. Subclinical hyperthyroidism (SHyper), a laboratory decrease in thyroid-stimulating hormone levels with peripheral thyroid hormone levels within the reference interval, is considered a medical condition, especially its impact on cardiac hemodynamics among young women. To determine the effects of subclinical thyroid dysfunction on hemodynamics in young women. clinical observation included two groups of women: (1) the main group consisted of 30 patients with subclinical hyperthyroidism, which was examined at the Family Medicine Clinic of the West Kazakhstan Marat Ospanov Medical University (Aktobe, Kazakhstan) and (2) the control group consisted of 30 practically healthy women. The groups were comparable in age (30–42), mean age 36.2±7.0 years. Blood pressure (BP) was measured, heart rate (HR) was counted, and thyroid hormones were determined. in the examined patients, clinical symptoms of pathology were not observed; laboratory tests determined a decrease in thyroid-stimulating hormone (TSH) in the main group of patients to 2.48±0.23 mIU/L in comparison with the control group 3.65±1.3 mIU/L, which was significant (p0.05) increase in blood pressure SBP/DBP from 122.34±2.7/78.3±2.7 to 127.8±3.1/83.2±2.1 mmHg and HR from 77.7±1.9 to 82.2±2.6 in 1 minute. A significant (r2 =0.482) interaction was determined between TSH -0.236 mIU/L and HP +20.3 in 1 minute, this could be a predictor of an increase in heart rate greater than the reference value (60–80 per minute), and an increased heart rate is considered a predictor of an increase in blood pressure. Subclinical hyperthyroidism may produce a significant laboratory decrease in TSH, without significant clinical symptoms of increased blood pressure. In conclusion, current observational experience suggests that small decreases in laboratory values of thyroid-stimulating hormone may affect blood pressure and heart rate. Subclinical hyperthyroidism (SHyper), a laboratory decrease in thyroid-stimulating hormone levels with peripheral thyroid hormone levels within the reference interval, is considered a medical condition, especially its impact on cardiac hemodynamics among young women. To determine the effects of subclinical thyroid dysfunction on hemodynamics in young women. clinical observation included two groups of women: (1) the main group consisted of 30 patients with subclinical hyperthyroidism, which was examined at the Family Medicine Clinic of the West Kazakhstan Marat Ospanov Medical University (Aktobe, Kazakhstan) and (2) the control group consisted of 30 practically healthy women. The groups were comparable in age (30–42), mean age 36.2±7.0 years. Blood pressure (BP) was measured, heart rate (HR) was counted, and thyroid hormones were determined. in the examined patients, clinical symptoms of pathology were not observed; laboratory tests determined a decrease in thyroid-stimulating hormone (TSH) in the main group of patients to 2.48±0.23 mIU/L in comparison with the control group 3.65±1.3 mIU/L, which was significant (p0.05) increase in blood pressure SBP/DBP from 122.34±2.7/78.3±2.7 to 127.8±3.1/83.2±2.1 mmHg and HR from 77.7±1.9 to 82.2±2.6 in 1 minute. A significant (r2 =0.482) interaction was determined between TSH -0.236 mIU/L and HP +20.3 in 1 minute, this could be a predictor of an increase in heart rate greater than the reference value (60–80 per minute), and an increased heart rate is considered a predictor of an increase in blood pressure. Subclinical hyperthyroidism may produce a significant laboratory decrease in TSH, without significant clinical symptoms of increased blood pressure. In conclusion, current observational experience suggests that small decreases in laboratory values of thyroid-stimulating hormone may affect blood pressure and heart rate. 2023-01-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/358 Stem Cell- and Stem Cell-Free-Based Therapies: Pros and Cons Mobarak, H.; Rahbarghazi, R.; Mahdipour, M. The efficiency of stem cell (SC)-based therapies has been proven in numerous animal and human studies. Along with the differentiation into several lineages, it is quite evident that SCs convey significant therapeutic effects in a paracrine manner via releasing various nano-sized extracellular vesicles (EVs) containing cytokines and bioactive factors. Notably, recent trials have stated the lack of stability and durability of the transplanted SCs at the site of injury for long periods, leading to the restrictions of SC in regenerative outcomes. Thus, EVs especially exosomes (Exos) gained much attention for therapeutic purposes and delivery purposes to the injury site. In contrast to whole-SC-based therapies, Exos can be used with fewer side effects. However, it should not be forgotten that both whole-SC- and cell-free-based options possess inherent pros and cons that necessitate being carefully evaluated before application in the clinical setting. Here, the effectiveness and limitations associated with whole-SCand SC-free-based therapies in the clinical setting are briefly discussed. The efficiency of stem cell (SC)-based therapies has been proven in numerous animal and human studies. Along with the differentiation into several lineages, it is quite evident that SCs convey significant therapeutic effects in a paracrine manner via releasing various nano-sized extracellular vesicles (EVs) containing cytokines and bioactive factors. Notably, recent trials have stated the lack of stability and durability of the transplanted SCs at the site of injury for long periods, leading to the restrictions of SC in regenerative outcomes. Thus, EVs especially exosomes (Exos) gained much attention for therapeutic purposes and delivery purposes to the injury site. In contrast to whole-SC-based therapies, Exos can be used with fewer side effects. However, it should not be forgotten that both whole-SC- and cell-free-based options possess inherent pros and cons that necessitate being carefully evaluated before application in the clinical setting. Here, the effectiveness and limitations associated with whole-SCand SC-free-based therapies in the clinical setting are briefly discussed. 2023-01-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/357 Processed Foods and Gut Health: A Mini Review of Microbiome Responses Baspakova, A.; Zhilisbayeva, K. R.; Umbetova, A. A.; Abitova, A. Zh. The present mini review delves into the intricate nexus between processed foods and gut health, with a focused exploration of the dynamic responses exhibited by the gut microbiome. The ubiquity of processed foods in contemporary diets has prompted inquiries into their potential ramifications for human physiological well-being. Given the acknowledged centrality of the gut microbiota in sustaining holistic health, deciphering the nuances of how processed foods impinge upon its constitution and functionality assumes critical significance. By methodically scrutinizing recent empirical investigations, this mini review elucidates the multifaceted manners through which processed foods interface with the complex web of the gut microbial consortium. It meticulously delineates alterations in microbial taxonomic diversity, community richness, and ecological equilibrium, thereby elucidating the putative mechanistic underpinnings driving the possible impact of processed food consumption on physiological equilibrium. Furthermore, the review cogitates upon the broader translational repercussions of these microbiome perturbations, cogently contemplating potential correlations with pathophysiologies encompassing but not limited to inflammation cascades, metabolic perturbations, and immune homeostasis dysregulation. By synthesizing the current compendium of empirical insights, this mini review proffers cogent perspectives into the intricate interplay between processed foods and gut health. It substantiates the exigency for augmented investigative endeavors, whilst advocating for judicious dietary selections that foster resilience and equilibrium within the intricate milieu of the gut microbiome. The present mini review delves into the intricate nexus between processed foods and gut health, with a focused exploration of the dynamic responses exhibited by the gut microbiome. The ubiquity of processed foods in contemporary diets has prompted inquiries into their potential ramifications for human physiological well-being. Given the acknowledged centrality of the gut microbiota in sustaining holistic health, deciphering the nuances of how processed foods impinge upon its constitution and functionality assumes critical significance. By methodically scrutinizing recent empirical investigations, this mini review elucidates the multifaceted manners through which processed foods interface with the complex web of the gut microbial consortium. It meticulously delineates alterations in microbial taxonomic diversity, community richness, and ecological equilibrium, thereby elucidating the putative mechanistic underpinnings driving the possible impact of processed food consumption on physiological equilibrium. Furthermore, the review cogitates upon the broader translational repercussions of these microbiome perturbations, cogently contemplating potential correlations with pathophysiologies encompassing but not limited to inflammation cascades, metabolic perturbations, and immune homeostasis dysregulation. By synthesizing the current compendium of empirical insights, this mini review proffers cogent perspectives into the intricate interplay between processed foods and gut health. It substantiates the exigency for augmented investigative endeavors, whilst advocating for judicious dietary selections that foster resilience and equilibrium within the intricate milieu of the gut microbiome. 2023-01-01T00:00:00Z